Acesion Pharma developing AF drug without safety issues

A company says it is developing a small molecule drug without major safety issues to treat a growing number of cases of atrial fibrillation, the most common cardiac arrhythmia.

Related Keywords

,Acesion Pharma ,Anders Gaarsdal Holst ,Gaarsdal Holst ,Preclinical Research ,Heart ,Cardiovascular Disease ,Harmacology ,Trial Defibrillation ,